The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Opthea Appoints Daniel Geffken As Interim Chief Financial Officer and Mike Campbell As Chief Commercial Officer
PUBLIC · CKDXFSep 06, 2024•almost 2 years ago
Company
Opthea
South Yarra
Description
Opthea announces executive leadership changes in finance and commercial sectors, as well as senior hires for biometrics, clinical operations, and market access, in preparation for the sozinibercept Phase 3 topline data readouts.
Company Information
Company
Opthea
Location
Chapel Street
South Yarra, Victoria, Australia
About
Opthea is a clinical stage biopharmaceutical company committed to developing innovative therapies to help improve visual function in patients suffering with retinal diseases. Our first in class novel therapeutic called OPT-302, is a VEGF-C/D ‘trap’, to be used in combination with existing standard of care anti-VEGF-A therapies to improve vision in patients, many of whom respond sub-optimally or become refractory to existing treatments.
Millions of people around the world suffer from impaired vision as a result of diabetes and old age. Our mission is to improve vision leading to a better quality of life.
Enquiries can be directed to: info@opthea.com
South Yarra